Clinical Trial Update: Long-Term Vesicular Monoamine Transporter II Imaging and Clinical Assessment of Parkinson's Disease Progression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on long-term vesicular monoamine transporter II imaging and clinical assessment for Parkinson's disease progression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-12-15